Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab for prevention of winter asthma exacerbations in atopic children
ACTRN12611001106921Phase 3Completed
- Sponsor
- The University of Queensland
- Start
- Mar 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Omalizumab with Placebo (2 arms). Primary endpoint: Proportion of children with acute asthma exacerbations during treatment period. Started Mar 2012; status: completed.
02
Drugs
omalizumab
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12611001106921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001106921.